Table 1 NfL concentrations at days 14 and 28 and mean daily levels in the first month of life.

From: Neurofilament light chain associates with IVH and ROP in extremely preterm infants

Medians (95% CI), [range] pg/mL, n.

Infant group

NfL day 14

NfL day 28

Mean NfL/day 1st month a

All (n = 178)

45.1 (38.6–51.2) [11.3–663.0], n = 119

24.1 (20.1–29.9) [6.5–1057.9], n = 149

55.0 (44.1–60.9) [11.9–435.2], n = 163

22–25 weeks GA (n = 57)

72.7 (52.5–86.4) [19.6–663.0], n = 38

41.5 (32.3–54.6) [12.7–501.0], n = 48

77.8 (66.6–94.2) [22.3–285.9], n = 54

25–26 weeks GA (n = 81)

37.4 (31.0–48.7) [11.3–365.0], n = 57

18.5 (15.9–23.2) [7.5–402.0], n = 69

43.6 (40.2–55.6) [12.9–144.9], n = 73

27 weeks GA (n = 40)

24.4 (19.8–42.8) [14.6–282.0], n = 24

12.7 (10.5–19.9) [6.5–1057.9], n = 32

37.6 (28.4–43.7) [11.9–435.2], n = 36

Standard nutrition (n = 94)

48.1 (40.7–55.1) [11.3–663.0], n = 65

25.7 (21.5–35.2) [6.5–1057.9], n = 79

64.1 (55.8–73.9) [12.9–435.2], n = 86

AA + DHA supplemented (n = 84)

41.3 (32.0–50.2) [17.1–365.0], n = 54

21.4 (16.0–29.2) [6.9–501], n = 70

44.2 (42.6–55.0) [11.9–261.7], n = 77

IVH4 (n = 12)

115.0 (81.2–246.0) [40.7–663.0], n = 8

46.8 (24.1–70.7) [13.4–73.3], n = 12

105.5 (69.3–117.5) [60.2–285.9], n = 11

IVH3 (n = 9)

51.0 (35.4–71.6) [31.2–200.0], n = 8

36.2 (20.3–98.7) [14.6–113.0], n = 8

74.4 (58.0–91.8) [40.3–140.6], n = 9

IVH2 (n = 25)

54.6 (50.3–181.0) [17.1–365.0], n = 21

38.0 (26.9–56.7) [6.9–218.0], n = 23

94.2 (66.6–124.4) [22.3–261.7], n = 23

IVH1 (n = 24)

28.8 (24.5–43.4) [17.9–126.0], n = 16

19.9 (12.2–35.2) [7.4–501.0], n = 20

43.3 (39.1–86.0) [20.5–241.3], n = 21

No IVH (n = 108)

39.7 (30.8–46.1) [11.3–144.0], n = 66

19.0 (15.9–23.7) [6.5–1057.9], n = 86

43.7 (39.0–54.2) [11.9–435.2], n = 99

Severe ROP (stage 3 and type 1) (n = 50)

55.1 (48.1–73.2) [19.1–663.0], n = 35

36.1 (26.9–51.9) [9.9–501.0], n = 43

72.0 (59.9–93.6) [22.3–285.9], n = 47

Mild/moderate ROP (stage 1 and 2) (n = 55)

34.0 (28.5–50.2) [16.1–183.0], n = 38

20.0 (17.3–30.4) [7.5–1057.9], n = 45

55.0 (44.1–66.5) [16.5–435.2], n = 51

No ROP (n = 72)

42.8 (26.3–50.3) [11.3–365.0], n = 45

19.3 (14.2–25.7) [6.5–108.0], n = 60

41.8 (36.8–49.1) [11.9–261.9], n = 64

  1. AA Arachidonic acid, CI confidence interval, DHA Docosahexaenoic acid, GA gestational age, IVH intraventricular hemorrhage, NfL neurofilament light chain, ROP retinopathy of prematurity.
  2. aCalculated as the mean of the area under the curve (AUC) of the concentrations during the first month of life.